NORTH CHICAGO, Ill., Sept. 12, 2023 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced top-line results from the Phase 3 SEQUENCE clinical trial evaluating risankizumab (SKYRIZI ®, 600 mg ...

RINVOQ™ (upadacitinib) Achieved Superiority Versus DUPIXENT® (dupilumab) For Primary and All Ranked Secondary Endpoints in Phase 3b Head-to-Head Study in Adults with Atopic Dermatitis ...

NORTH CHICAGO, Ill., April 9, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced positive top-line results from the Phase 3 SELECT-COMPARE ...

In those patients with spontaneous arrhythmia, PMVT/VF occurred in 20.7% of primary versus 21.8% of secondary implants, FVT in 19.0% versus 21.8%, and VT in 60.3% versus 56.4%, ...

ZA-305 was designed to enroll 120 men, 40 each into three parallel arms: Androxal®, approved topical gel and placebo. All three arms were blinded and "double dummied," meaning men received both ...

Figure 1: Common strategy for preparing chiral tertiary alcohols through face selective addition of nucleophiles to ketones. We explored a broader range of boronic esters, including alkyl (entries ...

The causes of primary versus secondary hyperthyroidism differ. Thyroid problems cause primary hyperthyroidism while problems in the pituitary gland cause secondary hyperthyroidism. Hyperthyroidism ...

ICD implantation was performed in 727 patients over the study period, 616 of whom were followed by the Electrophysiology Clinic at NMH for a mean of 3.8 ± 3.2 years. Of the 312 patients with ...